Aakaar Medical Technologies Reports Strong H1 FY27 Turnaround; Approves ESOPs and Leadership Addition
Aakaar Medical Technologies Ltd · Outcome · 30 Oct 2026, 11:18 pm
Aakaar Medical Technologies Reports Strong H1 FY27 Turnaround; Approves ESOPs and Leadership Addition Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lacs for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49 lacs. The company turned profitable with a net profit of ₹354.09 lacs compared to a net loss of ₹78.41 lacs on 30th Sep'25, driving basic and diluted EPS to ₹2.50 from negative ₹0.63. Additionally, the board approved granting 186,720 ESOPs at ₹10 face value and appointed Abhash Dilip Meswani as Whole-Time Director and Vice President – Xelix for five years.
Original exchange filing (PDF)
More announcements from Aakaar Medical Technologies Ltd
- Aakaar Medical Technologies Limited has informed the Exchange about the Publication Of Notice Of Postal Ballot and Remote E-Voting · 05 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about the Intimation Of Postal Ballot Notice sent to Shareholders. · 04 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Transcript · 02 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Link of Recording · 31 Oct 2026
- Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 31 Oct 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Investor Presentation · 30 Oct 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet · 30 Oct 2026
- AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and ESOP. · 30 Oct 2026
